Current situation // May 7, 2026

Hantavirus Outbreak Tracker: MV Hondius and Andes Virus

A source-led starter page for the 2026 cruise-linked hantavirus cluster, designed for fast public understanding: current counts, transmission risk, symptoms, prevention, and source links in one place.

No pandemic declaredSerious contained clusterWider public risk low

Situation dashboard

What is known right now

Counts can change as contact tracing and testing continue. This page treats WHO and PAHO as the source of truth for epidemiology, and news reports as operational context.

Reported cases

8Five laboratory-confirmed; three suspected.

Deaths

3Reported among the eight cases.

Virus identified

AndesA South American hantavirus with documented limited person-to-person spread.

Wider public risk

LowWHO assessment as of May 7, 2026.
Known route and response pointsIllustrative event path from official WHO reporting

Plain-language risk statement

Hantavirus is severe but uncommon. For this event, WHO says more cases may appear because Andes virus can incubate for weeks, but the wider public-health risk remains low. The highest concern is for people with direct exposure to infected rodents or close, prolonged contact with an infected person.

Event timeline

Key dates

  1. MV Hondius departed Ushuaia, Argentina

    WHO reports the vessel followed a South Atlantic route with remote ecological stops.

  2. First known case developed symptoms and died onboard

    Hantavirus was not initially suspected because symptoms resembled other respiratory illness.

  3. Saint Helena disembarkation and medical evacuation

    Some passengers disembarked before confirmation; contact tracing later expanded across multiple countries.

  4. WHO notified and Disease Outbreak News published

    Initial WHO public count: seven confirmed or suspected cases, including three deaths.

  5. WHO confirmed Andes virus and five confirmed cases

    The ship was sailing for the Canary Islands with WHO, Dutch, and ECDC experts supporting onboard assessment.

Symptoms and care

When to seek medical help

Hantavirus can progress quickly once respiratory symptoms begin. This page is informational and is not a substitute for medical care.

Early signs

  • Fever, chills, fatigue, and muscle aches
  • Headache, dizziness, nausea, vomiting, diarrhea, or abdominal pain
  • Symptoms can resemble flu or other respiratory infections

Urgent warning signs

  • Coughing, shortness of breath, or chest tightness
  • Rapid progression to pneumonia-like illness
  • Low blood pressure, shock, or severe weakness

Exposure timing

  • WHO notes Andes virus incubation can be up to six weeks
  • CDC says HPS symptoms usually appear 1 to 8 weeks after rodent exposure
  • Tell clinicians about rodent exposure, travel, or close contact with a case

After possible exposure

If you develop fever, gastrointestinal symptoms, coughing, shortness of breath, or rapid worsening after rodent exposure, travel through affected areas, or close contact with a confirmed case, contact a clinician or local health department and mention the exposure history.

Prevention

Reduce rodent exposure first

CDC and PAHO emphasize prevention because there is no specific vaccine or antiviral treatment for hantavirus infection.

  1. Avoid contact with rodent urine, droppings, saliva, and nesting material.
  2. Seal holes, remove food sources, and control rodents around homes, workplaces, cabins, vehicles, and campsites.
  3. Ventilate enclosed spaces before cleanup and use disinfectant so contaminated dust is not stirred into the air.
  4. Seek medical care promptly for compatible symptoms after possible rodent exposure or close contact with a confirmed case.

Regional context

Why public-health agencies are watching

PAHO reported that in 2025, through epidemiological week 47, eight countries in the Americas reported 229 confirmed HPS cases and 59 deaths. The disease remains uncommon, but surveillance matters because cases can be severe and environmental exposure risks vary by region.

FAQ

Fast answers

Is this a declared hantavirus pandemic?

No. WHO describes this as a serious incident linked to a cruise ship cluster and assesses the public health risk as low as of May 7, 2026.

Can hantavirus spread from person to person?

Most hantaviruses do not. Andes virus, the species confirmed in this event, has documented limited human-to-human transmission in close and prolonged contact settings.

What should someone do after possible exposure?

Monitor for fever, gastrointestinal symptoms, cough, shortness of breath, or rapid worsening, and contact a clinician or local health department. Mention rodent exposure, travel, and any contact with a confirmed case.

Is there a vaccine or specific antiviral treatment?

CDC and PAHO describe treatment as supportive care. Prevention focuses on avoiding rodent exposure and safe cleanup.

Source log

Official sources first

This starter page is designed to be updated manually or wired to a future editorial workflow. Keep official agencies above news media when counts conflict.

Primary official sources used for this page
SourceDateUse on page
WHO response to hantavirus cases linked to a cruise shipWorld Health OrganizationMay 7, 2026Current case count, risk assessment, response actions.
WHO Director-General media briefingWorld Health OrganizationMay 7, 2026Operational timeline, countries notified, ship status.
Disease Outbreak News: Hantavirus cluster linked to cruise ship travelWorld Health OrganizationMay 4, 2026Initial public DON, symptoms, exposure window, baseline case definitions.
PAHO supports the international responsePan American Health OrganizationMay 7, 2026Americas context, 2025 regional counts, surveillance guidance.
About HantavirusU.S. CDCMay 13, 2024General transmission, symptoms, treatment, HPS background.
Hantavirus PreventionU.S. CDCMay 13, 2024Rodent exposure reduction and safe cleanup principles.

Media watch

News links help track public operations, travel logistics, and local response. Official public-health agencies remain the baseline for medical and epidemiological claims.